A Harvard professor arrested earlier this year for failing to disclose ties to China’s Thousand Talents Program was indicted for making false statements to federal authorities regarding that work in Wuhan, China.

A federal court judge reversed a $200 million award against Gilead over claims of patent violations for its hep C drugs due to patterns of misconduct by Merck & Co.